I don't want to ask a question.
I spoke to Mr. Weston about this before we started today. I think he shares this concern.
We've just mentioned these two drugs, but there certainly could be, in the future, derivatives—there may already be derivatives—along the same lines. I think it behooves the government to be looking now to add in the future, and maybe the near future, additional ones using this section as the base, or, as Mr. Lemay has raised, to use the regulations to bring additional drugs of this nature under the purview of this legislation.
That's all I have, Mr. Chair. Thank you.